USTEKINUMAB
ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
USTEKINUMAB (10767Q)
10767Q
Manner of administration:Injection
Restriction
Indication: Severe psoriatic arthritis
Treatment phase: First continuing treatment
Restriction
Indication: Severe psoriatic arthritis
Treatment phase: First continuing, Subsequent continuing treatment - balance of supply
Restriction
Indication: Severe psoriatic arthritis
Treatment phase: Subsequent continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $789.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Stelara | |||||